MX336444B - Metodo y aparato de medicion de sistema inmune y de oxigeno y de deteccion de farmaco. - Google Patents

Metodo y aparato de medicion de sistema inmune y de oxigeno y de deteccion de farmaco.

Info

Publication number
MX336444B
MX336444B MX2012012433A MX2012012433A MX336444B MX 336444 B MX336444 B MX 336444B MX 2012012433 A MX2012012433 A MX 2012012433A MX 2012012433 A MX2012012433 A MX 2012012433A MX 336444 B MX336444 B MX 336444B
Authority
MX
Mexico
Prior art keywords
immune
screening method
drug screening
oxygen system
system measuring
Prior art date
Application number
MX2012012433A
Other languages
English (en)
Other versions
MX2012012433A (es
Inventor
Samir Sofer
Original Assignee
Samir Sofer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samir Sofer filed Critical Samir Sofer
Publication of MX2012012433A publication Critical patent/MX2012012433A/es
Publication of MX336444B publication Critical patent/MX336444B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método y aparato para monitorear la salud en relación con la función del sistema inmune y para medir los efectos de toxinas y otros esfuerzos. Un método para detectar previamente fármacos para la sonda farmacéutica. Un método para usar un inmunograma como una herramienta de investigación. Un método para preparar compuestos o fármacos para el tratamiento, la terapia o la cura de enfermedades.
MX2012012433A 2010-04-27 2011-04-27 Metodo y aparato de medicion de sistema inmune y de oxigeno y de deteccion de farmaco. MX336444B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32840910P 2010-04-27 2010-04-27
PCT/US2011/034051 WO2011139733A2 (en) 2010-04-27 2011-04-27 Immune and oxygen system measuring and drug screening method and apparatus

Publications (2)

Publication Number Publication Date
MX2012012433A MX2012012433A (es) 2013-02-26
MX336444B true MX336444B (es) 2016-01-19

Family

ID=44904347

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012433A MX336444B (es) 2010-04-27 2011-04-27 Metodo y aparato de medicion de sistema inmune y de oxigeno y de deteccion de farmaco.

Country Status (20)

Country Link
US (2) US9140712B2 (es)
EP (1) EP2564204B1 (es)
JP (2) JP5698835B2 (es)
KR (1) KR101332003B1 (es)
CN (1) CN103003698B (es)
AU (1) AU2011248644B2 (es)
BR (1) BR112012027351B1 (es)
CA (1) CA2797097C (es)
CO (1) CO6640294A2 (es)
DK (1) DK2564204T3 (es)
ES (1) ES2611857T3 (es)
IL (1) IL222603B (es)
MX (1) MX336444B (es)
NZ (1) NZ603749A (es)
PL (1) PL2564204T3 (es)
PT (1) PT2564204T (es)
RU (1) RU2574000C2 (es)
SG (1) SG185004A1 (es)
WO (1) WO2011139733A2 (es)
ZA (1) ZA201208847B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10900954B2 (en) * 2015-04-14 2021-01-26 Blaze Medical Devices, Inc. Method and system for inducing controlled and varied fluid stresses by bead oscillation
CN105823807B (zh) * 2016-01-04 2018-04-20 浙江农林大学 抗癌药物羟喜树碱药效检测装置及检测方法
IL261089B2 (en) 2016-02-19 2023-04-01 Nant Holdings Ip Llc Methods of immunogenic regulation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041933A (en) * 1975-04-11 1977-08-16 Siemens Aktiengesellschaft Electrode for polarographic measurements in physiological media
SU1739295A1 (ru) 1989-08-11 1992-06-07 Ленинградский Государственный Институт Усовершенствования Врачей Им.С.М.Кирова Способ определени стимулирующего действи фармпрепаратов на кислородсв зывающую функцию крови
DE69331951T2 (de) * 1992-08-19 2003-01-09 Lawrence A Lynn Vorrichtung zur anzeige von apnoe während des schlafens
DE19612425C2 (de) * 1995-03-31 2000-08-31 Nihon Kohden Corp Apparat zur Messung von Hämoglobinkonzentration
US5863460A (en) * 1996-04-01 1999-01-26 Chiron Diagnostics Corporation Oxygen sensing membranes and methods of making same
US6532958B1 (en) * 1997-07-25 2003-03-18 Minnesota Innovative Technologies & Instruments Corporation Automated control and conservation of supplemental respiratory oxygen
JP2001178817A (ja) * 1999-12-24 2001-07-03 Terumo Corp 人工腎臓用装置およびこれを用いた品質評価装置ならびに流体回路
US7025734B1 (en) * 2001-09-28 2006-04-11 Advanced Cardiovascular Systmes, Inc. Guidewire with chemical sensing capabilities
EP1536730A2 (en) * 2002-09-10 2005-06-08 Euro-Celtique, S.A. Apparatus and method for non-invasive measurement of blood constituents
US6925852B2 (en) * 2002-11-05 2005-08-09 Kenneth Susko Oxygen monitoring device
US20040133079A1 (en) * 2003-01-02 2004-07-08 Mazar Scott Thomas System and method for predicting patient health within a patient management system
US7072804B2 (en) 2004-09-28 2006-07-04 Agilent Technologies, Inc. Digital trigger filter for a real time digital oscilloscope
US20060171845A1 (en) * 2005-01-31 2006-08-03 Dakota Technologies, Inc. Sensors for measuring analytes
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
WO2009014616A1 (en) * 2007-07-26 2009-01-29 Duke University Measuring amount of bound and combined nitric oxide in blood

Also Published As

Publication number Publication date
NZ603749A (en) 2014-08-29
US9140712B2 (en) 2015-09-22
US20130041239A1 (en) 2013-02-14
WO2011139733A3 (en) 2012-03-29
SG185004A1 (en) 2012-11-29
MX2012012433A (es) 2013-02-26
BR112012027351A2 (pt) 2020-07-14
WO2011139733A2 (en) 2011-11-10
CN103003698B (zh) 2015-09-16
JP2015028490A (ja) 2015-02-12
RU2012150435A (ru) 2014-06-10
PL2564204T3 (pl) 2017-07-31
ZA201208847B (en) 2013-09-25
DK2564204T3 (en) 2017-05-08
AU2011248644A1 (en) 2012-12-13
JP5698835B2 (ja) 2015-04-08
RU2574000C2 (ru) 2016-01-27
EP2564204B1 (en) 2016-11-09
BR112012027351B1 (pt) 2022-02-22
IL222603A0 (en) 2012-12-31
PT2564204T (pt) 2017-02-03
ES2611857T3 (es) 2017-05-10
KR101332003B1 (ko) 2013-11-25
IL222603B (en) 2018-11-29
JP2013529301A (ja) 2013-07-18
EP2564204A4 (en) 2013-09-04
AU2011248644B2 (en) 2016-06-02
KR20130028935A (ko) 2013-03-20
CO6640294A2 (es) 2013-03-22
CA2797097A1 (en) 2011-11-10
US9811635B2 (en) 2017-11-07
CA2797097C (en) 2016-09-20
CN103003698A (zh) 2013-03-27
US20150356266A1 (en) 2015-12-10
EP2564204A2 (en) 2013-03-06

Similar Documents

Publication Publication Date Title
CY1123208T1 (el) Κυκλικα παραγωγα εστερων βορονικου οξεος, μεθοδος για την παρασκευη και θεραπευτικες χρησεις αυτων
IL222251A0 (en) Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
MX353482B (es) Metodos para el tratamiento del cancer y enfermedades inflamatorias utilizando cereblon como predictor.
WO2012040248A3 (en) Automatic association of medical elements
AU2011328009A8 (en) Compounds and methods for treating pain
MX2021010672A (es) Uso de un anticuerpo que tiene la capacidad para ligarse a clnd6 en el tratamiento o prevención de cáncer.
EP2651364A4 (en) Systems, methods and apparatus for delivering nerve stimulation to a patient with physician oversight
IL222383A0 (en) Apparatus, system and method for detection and delivery of a medical dose
MX2013006591A (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
MX340090B (es) Analogos de spliceostatina.
MX348914B (es) Dispositivo de diagnostico, dispositivo terapeutico, y usos de los mismos.
MX2019006900A (es) Metodos de monitoreo terapeutico de farmacos depuradores de nitrogeno.
IN2012DN06309A (es)
EP2834786A4 (en) Method, system and apparatus for medication therapy management programs
MX2021006111A (es) Composicion farmaceutica que comprende un anticuerpo anti-gm-csf para usarse en el tratamiento de artritis reumatoide.
EP4252742A3 (en) Fluticasone furoate in the treatment of copd
MX336444B (es) Metodo y aparato de medicion de sistema inmune y de oxigeno y de deteccion de farmaco.
WO2016019350A3 (en) Microscale bioprocessing system and method for protein manufacturing from human blood
MX2013003168A (es) Anticuerpo contra ephrin b2 y su uso.
MX2012000952A (es) Metodo para pronosticar la ganancia de peso asociada con una terapia farmaceutica.
UA69880U (ru) Способ премедикации у онкологических больных
UA71871U (ru) Способ диагностики эффективности антибиотикотерапии у больных лайм-борелиозом
UA59658U (ru) Способ лечения больных с синдромом повышенной усталости на фоне хронической патологии гепатобилиарной системы
UA59969U (ru) Способ прогнозирования течения заболевания у больных раком желудка
UA56025U (ru) Способ определения запрещенных наркотиков и сильнодействующих лекарственных средств в биологическом материале человека